Tag: release

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- In a moment when consumers are demanding clarity and credibility across every purchase—from clean beauty to conflict-free diamonds—She Said Yes, the sustainable fine jewelry brand, is leading with proof announcing rigorous testing, international certification, and thousands of verified five-star reviews.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Neogen Corporation (NASDAQ:NEOG), Alto Neuroscience, Inc. (NYSE:ANRO), RxSight, Inc. (NASDAQ:RXST), and Replimune Group, Inc. (NASDAQ:REPL). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- With consumers increasingly searching for comfortable rings, hypoallergenic fine jewelry, and daily-wear engagement rings, She Said Yes is answering the call—introducing a new design standard that blends beauty with all-day comfort.

If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses IRobot (IRBT) To Contact Him Directly To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Attorneys Encourage Investors Who Suffered Losses In Petco (WOOF) To Contact Him Directly To Discuss Their Options

SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Quick Custom Intelligence (QCI) today announced the acquisition of VizExplorer, bringing the acclaimed casino analytics platform back under the leadership of its original visionaries, Dr. Ralph Thomas and Andrew Cardno. As innovators behind both VizExplorer and QCI, Thomas and Cardno expressed pride and excitement at “getting VizExplorer back” and integrating its powerful tools into QCI’s growing suite of solutions. This reunion not only marks a personal milestone for the founders, but also promises to enhance QCI’s offerings with VizExplorer’s unique technologies and proven industry track record blog.vizexplorer.com   sccgmanagement.com.

WALTHAM, Mass., July 28, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the U.S. Food and Drug Administration (FDA) has approved EMPAVELI^® (pegcetacoplan) as the first treatment for C3 glomerulopathy (C3G) or primary immune complex membranoproliferative glomerulonephritis (IC-MPGN) in patients 12 years of age and older, to reduce proteinuria. C3G and primary IC-MPGN are rare kidney diseases, affecting 5,000 people in the United States.¹

New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025
In the evolving world of performance fitness, strength building isn’t just about lifting heavier—it’s about training smarter, fueling properly, and choosing science-backed supplements that support sustainable muscle growth. As more athletes, fitness enthusiasts, and bodybuilders shift away from synthetic enhancers, a natural powerhouse is gaining serious ground: CrazyBulk strength training supplements.

New York City, NY, July 28, 2025 (GLOBE NEWSWIRE) -- Build muscle mass and keep growing stronger with CrazyBulk’s legal strength training supplements. Explore the best stacks for real power gains in 2025
In the evolving world of performance fitness, strength building isn’t just about lifting heavier—it’s about training smarter, fueling properly, and choosing science-backed supplements that support sustainable muscle growth. As more athletes, fitness enthusiasts, and bodybuilders shift away from synthetic enhancers, a natural powerhouse is gaining serious ground: CrazyBulk strength training supplements.

ATLANTA, GA, July 28, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB), a self-managed healthcare real estate investment company that invests primarily in real estate purposed for senior living and long-term care, today issues the following statement to its common stock shareholders.